A new WA charitable foundation that provides research into pancreatic, gastrointestinal and rare cancers is aiming to develop cancer treatments of the future.

Warpnine CEO Meg Croucher and oncologist Dr Andrew Dean told Liam Bartlett on 6PR Mornings the West Australian first, not-for-profit group aims to get people who have been diagnosed with pancreatic, gastro-intestinal and rare cancers into new treatment to try extend their life.

“Pancreatic cancer generally there’d be 4200 people per year diagnosed and it pretty much has one of the worst survival rates of the tumours and one of the highest death rates,” Dr Dean said.

“It comes down to funding … and it’s my role to go out and talk to individuals and philanthropists, trusts and corporates and try to garner their support for something that really does need some attention, much-needed funding and greater awareness,” Ms Croucher said.

For more information visit www.warpnine.org.au